INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,000 | -23.0% | 72,683 | +3.4% | 0.00% | – |
| Q2 2023 | $639,000 | +63.4% | 70,308 | +16.1% | 0.00% | – |
| Q1 2023 | $391,000 | +1.8% | 60,539 | 0.0% | 0.00% | – |
| Q4 2022 | $384,000 | +2.4% | 60,539 | +0.0% | 0.00% | – |
| Q3 2022 | $375,000 | -27.9% | 60,528 | +2.8% | 0.00% | – |
| Q2 2022 | $520,000 | +19.8% | 58,867 | +14.1% | 0.00% | – |
| Q1 2022 | $434,000 | -3.3% | 51,606 | +17.2% | 0.00% | – |
| Q4 2021 | $449,000 | -81.7% | 44,031 | -65.2% | 0.00% | -100.0% |
| Q3 2021 | $2,455,000 | +110.2% | 126,411 | +90.2% | 0.00% | – |
| Q2 2021 | $1,168,000 | +49.9% | 66,458 | +1.4% | 0.00% | – |
| Q1 2021 | $779,000 | -20.6% | 65,548 | +15.0% | 0.00% | – |
| Q4 2020 | $981,000 | +98000.0% | 56,998 | +54705.8% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 104 | +3.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 101 | +12.2% | 0.00% | – |
| Q1 2020 | $0 | – | 90 | +200.0% | 0.00% | – |
| Q3 2019 | $0 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |